Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soon Thye Lim

Showing results (81-90 of 184) with videos related to

Pageof 19
Sort By:
Annals of Hematology|November 14, 2024
Real-world outcomes of diffuse large B-cell lymphoma treated with frontline R-CHOP(-like) regimens in an Asian multi-ethnic populationRyan Mao Heng Lim, Jing Yuan Tan, Ya Hwee Tan, et al.
Plos One|April 29, 2022
Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNAJonathan Poh, Kao Chin Ngeow, Michelle Pek, et al.
Journal of Hematology|September 16, 2021
Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell LymphomaJing Yuan Tan, Tian Yu Qiu, Jianbang Chiang, et al.
Pathology|December 1, 2012
Relationship between atypical T- and B-cell size predicts survival in peripheral T-cell lymphomas with large B-cellsLeonard Hwan Cheong Tan, Soo Yong Tan, Tiffany Tang, et al.
Journal of Medical Genetics|March 24, 2017
Impact of subsidies on cancer genetic testing uptake in SingaporeShao-Tzu Li, Jeanette Yuen, Ke Zhou, et al.
Annals of Hematology|August 25, 2025
Outcomes of primary CNS lymphoma treated with combined immunochemotherapy with whole-brain radiotherapyYa Hwee Tan, Ryan Mao Heng Lim, Jing Yuan Tan, et al.
Blood Cancer Journal|December 16, 2017
Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centersTiffany Tang, Lay Poh Khoo, Cindy Lim, et al.
Haematologica|January 28, 2017
Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II studyVincent Ribrag, Won Seog Kim, Reda Bouabdallah, et al.
Blood Cancer Journal|November 26, 2024
Indolent nodal T follicular helper cell lymphomas-A case seriesJie Wang, Chun En Yau, Chen Ee Low, et al.
Leukemia & Lymphoma|June 10, 2022
Clinicopathological factors affecting prognosis in marginal zone lymphoma in Asian patients: a cohort studyYao Hao Teo, Yao Neng Teo, Lay Poh Khoo, et al.
Pageof 19

Showing results (81-90 of 184) with videos related to

Sort By:
Pageof 19
Annals of Hematology|November 14, 2024
Real-world outcomes of diffuse large B-cell lymphoma treated with frontline R-CHOP(-like) regimens in an Asian multi-ethnic populationRyan Mao Heng Lim, Jing Yuan Tan, Ya Hwee Tan, et al.
Plos One|April 29, 2022
Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNAJonathan Poh, Kao Chin Ngeow, Michelle Pek, et al.
Journal of Hematology|September 16, 2021
Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell LymphomaJing Yuan Tan, Tian Yu Qiu, Jianbang Chiang, et al.
Pathology|December 1, 2012
Relationship between atypical T- and B-cell size predicts survival in peripheral T-cell lymphomas with large B-cellsLeonard Hwan Cheong Tan, Soo Yong Tan, Tiffany Tang, et al.
Journal of Medical Genetics|March 24, 2017
Impact of subsidies on cancer genetic testing uptake in SingaporeShao-Tzu Li, Jeanette Yuen, Ke Zhou, et al.
Annals of Hematology|August 25, 2025
Outcomes of primary CNS lymphoma treated with combined immunochemotherapy with whole-brain radiotherapyYa Hwee Tan, Ryan Mao Heng Lim, Jing Yuan Tan, et al.
Blood Cancer Journal|December 16, 2017
Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centersTiffany Tang, Lay Poh Khoo, Cindy Lim, et al.
Haematologica|January 28, 2017
Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II studyVincent Ribrag, Won Seog Kim, Reda Bouabdallah, et al.
Blood Cancer Journal|November 26, 2024
Indolent nodal T follicular helper cell lymphomas-A case seriesJie Wang, Chun En Yau, Chen Ee Low, et al.
Leukemia & Lymphoma|June 10, 2022
Clinicopathological factors affecting prognosis in marginal zone lymphoma in Asian patients: a cohort studyYao Hao Teo, Yao Neng Teo, Lay Poh Khoo, et al.
Pageof 19